I would say that would make them right in the speculative intellect but wrong in the practical intellect. There should ideally be harmony between the speculative and practical intellects in that conclusions reached speculatively that have a practical bearing should be acted upon. However, due to a lack of courage one's practical intellect might not be willing to carry out the conclusions reached by the speculative intellect.
So such a person would be right, in one sense, and wrong in a different sense.
Hey Conklw you could be correct. The charts shows that there was buying in the 2-3 range but the 5 year shows that 3-4 is the stock price average.
How can u say this stock will go to a penny.When its falling apart every day its down, its only a matter of time before its down to 0.0001
OK - right now my intention is to stay for the longer term as I feel a lot of things will be happening within the next 2 to 5 years and the upside could be significant. On the near and short term if we have a correction I intend to purchase additional shares and scale in from 15 down to 12 if it correct to that level. I do not think it will happen but I am prepared to purchase and even double on my existing position. I am building my reserve to take advantage of any sell off in the coming summer months. If the market does not correct AMPH should reach 23-25 by the end of this year. Right now I do not believe I will sell all my shares but may be inclined to do so if I see a fundamental change in the direction of the company's business and a lack of visibility of their growth.
Sentiment: Strong Buy
If we assume platform works which I believe CNCE ownership does believe then less than $50 would not even be considered.
Sentiment: Strong Buy
Get out while you can shorties; you have been warned. When portable spirometry are given to docs and prescribing afrezza is as easy as giving out Lipitor, in conjunction with consumer ads, Afrezza sales will pick up exponentially. Then to top it all off, mnkd announces another partner for TS projects. If you wait until then, the share price will be out of control $25-50/sh
just look up the following post by me below...and you'll see it's a reply to a thread entitled, "Hater Shanghaishark strikes again" posted by none other than KBC on December 13th at 11:43 pm...accompanied by the yahoo notice "This topic is deleted."
kbc = nicoMpoop = Lying Moron...haha
shanghaishark • Dec 14, 2014 12:00 AM Remove 0users liked this postsusers disliked this posts2Reply
hey preacher - you tell me to go die...and call ME a hater? haha
plz keep posting kbc...you're priceless!
btw...does anyone care what you "believe"? how about backing up ur opinions for once with some facts? heck, you haven't posted anything since the inception of ur new id except "i hate shangahi" posts and pumping baloney statements like the ones above.
also, try googling "apdn" and you might not have to rely on Pumpers to find articles 4 u...try lifting a finger other than the middle one for a change, preach...haha
but please continue following their advice to load up...especially on those failed breakouts...gl!
oh..and btw..preacher, too bad you didn't get in like me before the first surge - get out - and then get back in at $2.50...i guess the Big Guy just wasn't Looking out for you on that One... :-( Less
First, UC Davis doesn't tie up with the CHP accident you referred to in your May 26th post. That accident occurred on Mon, May 25... so are you saying that there is rumor of a different patient treated on May 20?
Second, I check the clinicaltrials site periodically, and it has been updated a few times since the trial re-opened in end of March. Here's the log (after trial reopened), that you can access by clicking 'history of changes' and following the trail:
2015_03_30 Study Changes Recruitment status, Recruitment, Location/Contact, Misc.
2015_03_31 Study Changes Location/Contact, Misc.
2015_04_07 Study Changes Recruitment, Location/Contact, Misc.
2015_05_19 Study Changes Recruitment, Location/Contact, Misc.
2015_05_20 Study Changes Location/Contact, Misc.
Sentiment: Strong Buy
You are insane..can't answer a direct question..good bye
From information we have learned on the internet, a unlikely group of Stockholders, Subscribers and actual Travelers may be combining strong opinions about how AWAY conducts its allocation of Traveler Inquires in a class action. We spoke with one AWAY stockholder who agreed to comment with anonymity, "Well, from what I've read, some folks feel that our management team is not addressing the needs of our clients consistently. That would be bad business." After a number of attempts, we reached an AWAY subscriber who was familiar with the situation. Again, she spoke with anonymity. "This isn't anything new with Homeaway. They've been directing folks to other options based upon some unknown criteria for a couple of years now. We're now paying 30% more for 50% less inquiries. What is new is that they recently took all our sort options away for only two options. It's just not reliable information at this time. I hope they figure out who their real customers are soon." We'll get back with you folks as this interesting drama plays out over the next few days.
11 m people watch America got talent and more will follow his progress on you tube. I am interested in this from gg investor standpoint but this boy is truly inspiring and I wish the best for him. The glasses (to me) don't look bad at all and in fact look pretty natural other than the electronic bar on one side. Check this out on you tube. If the link below does not work google America got talent gg.
I believe this legal stuff has peaked. Dirt bag lawyers will run the course. May hit 15 but more likely 30 IMO